* Enovis Corp ENOV.N reported quarterly adjusted earnings
of 62
cents per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of 61
cents. The mean expectation of eleven analysts for the quarter
was for earnings of 59 cents per share. Wall Street expected
results to range from 50 cents to 63 cents per share.
* Revenue rose 22.6% to $525.16 million from a year ago;
analysts
expected $526.01 million.
* Enovis Corp's reported EPS for the quarter was a loss
of 34
cents.
* The company reported a quarterly loss of $18.64 million.
* Enovis Corp shares had fallen by 7.1% this quarter and
lost 25.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Enovis Corp is
$75.00
This summary was machine generated from LSEG data August 7 at
01:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.59 0.62 Beat
Mar. 31 2024 0.48 0.50 Beat
Dec. 31 2023 0.74 0.79 Beat
Sep. 30 2023 0.54 0.56 Beat